These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20829612)

  • 21. BMP action in the pituitary: its possible role in modulating somatostatin sensitivity in pituitary tumor cells.
    Otsuka F; Tsukamoto N; Miyoshi T; Iwasaki Y; Makino H
    Mol Cell Endocrinol; 2012 Feb; 349(2):105-10. PubMed ID: 22056414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
    Castillo V; Theodoropoulou M; Stalla J; Gallelli MF; Cabrera-Blatter MF; Haedo MR; Labeur M; Schmid HA; Stalla GK; Arzt E
    Neuroendocrinology; 2011; 94(2):124-36. PubMed ID: 21525729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways.
    Luque RM; Gahete MD; Hochgeschwender U; Kineman RD
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E395-403. PubMed ID: 16825606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells.
    Gatto F; Arvigo M; Amarù J; Campana C; Cocchiara F; Graziani G; Bruzzone E; Giusti M; Boschetti M; Ferone D
    Pituitary; 2019 Feb; 22(1):89-99. PubMed ID: 30483918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The somatostatin receptor subtype 5 in neuroendocrine tumours.
    van der Hoek J; Lamberts SW; Hofland LJ
    Expert Opin Investig Drugs; 2010 Mar; 19(3):385-99. PubMed ID: 20151855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
    Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin and somatostatin receptors: from basic concepts to clinical applications.
    De Martino MC; Hofland LJ; Lamberts SW
    Prog Brain Res; 2010; 182():255-80. PubMed ID: 20541669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update on the biochemical diagnosis of congenital ACTH insufficiency.
    Mehta A; Hindmarsh PC; Dattani MT
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):307-14. PubMed ID: 15730412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.
    de Bruin C; Feelders RA; Lamberts SW; Hofland LJ
    Rev Endocr Metab Disord; 2009 Jun; 10(2):91-102. PubMed ID: 18642088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
    Lupp A; Hunder A; Petrich A; Nagel F; Doll C; Schulz S
    Neuroendocrinology; 2011; 94(3):255-64. PubMed ID: 21952553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential indications for somatostatin analogs in Cushing's syndrome.
    Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
    J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
    Teshima T; Hara Y; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
    Ronchi CL; Ferrante E; Rizzo E; Giavoli C; Verrua E; Bergamaschi S; Lania AG; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):608-12. PubMed ID: 18410544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
    Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
    Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.
    van der Hoek J; Waaijers M; van Koetsveld PM; Sprij-Mooij D; Feelders RA; Schmid HA; Schoeffter P; Hoyer D; Cervia D; Taylor JE; Culler MD; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E278-87. PubMed ID: 15769796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells.
    Strowski MZ; Dashkevicz MP; Parmar RM; Wilkinson H; Kohler M; Schaeffer JM; Blake AD
    Neuroendocrinology; 2002 Jun; 75(6):339-46. PubMed ID: 12065886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion.
    de Bruin C; Hofland LJ; Nieman LK; van Koetsveld PM; Waaijers AM; Sprij-Mooij DM; van Essen M; Lamberts SW; de Herder WW; Feelders RA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):455-62. PubMed ID: 22090282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine actions of cortistatin: in vivo studies.
    Broglio F; Grottoli S; Arvat E; Ghigo E
    Mol Cell Endocrinol; 2008 May; 286(1-2):123-7. PubMed ID: 18281148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.
    de Bruin C; Pereira AM; Feelders RA; Romijn JA; Roelfsema F; Sprij-Mooij DM; van Aken MO; van der Lelij AJ; de Herder WW; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1118-24. PubMed ID: 19141584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.